Literature DB >> 7946799

Role of ACE inhibitors in hypertension with left ventricular hypertrophy.

A M Richards1, M G Nicholls, I G Crozier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7946799      PMCID： PMC1025589          DOI： 10.1136/hrt.72.3_suppl.s24

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  78 in total

1.  Body weight is more important than family history of hypertension for left ventricular function.

Authors:  M B Suurküla; J Wikstrand; G Berglund; R Sivertsson
Journal:  Hypertension       Date:  1991-05       Impact factor: 10.190

2.  Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study.

Authors:  W B Kannel; T Gordon; W P Castelli; J R Margolis
Journal:  Ann Intern Med       Date:  1970-06       Impact factor: 25.391

3.  Coronary vascular remodeling and myocardial fibrosis in the rat with renovascular hypertension. Response to captopril.

Authors:  J E Jalil; J S Janicki; R Pick; K T Weber
Journal:  Am J Hypertens       Date:  1991-01       Impact factor: 2.689

4.  Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy.

Authors:  M V Raynolds; M R Bristow; E W Bush; W T Abraham; B D Lowes; L S Zisman; C S Taft; M B Perryman
Journal:  Lancet       Date:  1993-10-30       Impact factor: 79.321

5.  Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death.

Authors:  A J Marian; Q T Yu; R Workman; G Greve; R Roberts
Journal:  Lancet       Date:  1993-10-30       Impact factor: 79.321

6.  Left ventricular hypertrophy: effect on survival.

Authors:  J M Sullivan; R V Vander Zwaag; F el-Zeky; K B Ramanathan; D M Mirvis
Journal:  J Am Coll Cardiol       Date:  1993-08       Impact factor: 24.094

7.  Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension.

Authors:  M H Alderman; S Madhavan; W L Ooi; H Cohen; J E Sealey; J H Laragh
Journal:  N Engl J Med       Date:  1991-04-18       Impact factor: 91.245

8.  Plasma renin activity and ischemic heart disease.

Authors:  T W Meade; J A Cooper; W S Peart
Journal:  N Engl J Med       Date:  1993-08-26       Impact factor: 91.245

9.  Cardiac performance after reduction of myocardial hypertrophy.

Authors:  R E Schmieder; F H Messerli; D Sturgill; G E Garavaglia; B D Nunez
Journal:  Am J Med       Date:  1989-07       Impact factor: 4.965

10.  Importance of overweight in studies of left ventricular hypertrophy and diastolic function in mild systemic hypertension.

Authors:  B Egan; M A Fitzpatrick; J Juni; A J Buda; A Zweifler
Journal:  Am J Cardiol       Date:  1989-10-01       Impact factor: 2.778
View more
  2 in total

Review 1.  Age-related changes in cardiac physiology. Can they be postponed or treated by drugs?

Authors:  A Svanborg
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 3.923

2.  Fosinopril reduces left ventricular mass in untreated hypertensive patients: a controlled trial.

Authors:  B M Cheung; C P Lau
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.